Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / CALL
-
Number of holders
-
0
-
Price
-
$101.65
Significant Holders of VALEANT PHARMACEUTICALS INTL - CALL as of Q4 2015
9 filings reported holding 91911K902 - VALEANT PHARMACEUTICALS INTL - CALL as of Q4 2015.
VALEANT PHARMACEUTICALS INTL - CALL has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of shares
.
Largest 9 shareholders include JPMORGAN CHASE & CO (2,200,000 shares), GROUP ONE TRADING, L.P. (1,485,200 shares), Pentwater Capital Management LP (985,000 shares), CITADEL ADVISORS LLC (703,800 shares), EcoR1 Capital, LLC (126,500 shares), Timber Hill LLC (92,700 shares), SIMPLEX TRADING, LLC (3,412 shares), AMERICAN INTERNATIONAL GROUP INC (15 shares), and Catalyst Capital Advisors LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.